Overview of the Virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for Below-the-Knee Lesions in Critical Limb Ischemia.

Saved in:
Bibliographic Details
Title: Overview of the Virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for Below-the-Knee Lesions in Critical Limb Ischemia.
Authors: Case, Brian C.1 (AUTHOR), Torguson, Rebecca2 (AUTHOR), Zhang, Cheng1 (AUTHOR), Waksman, Ron1 (AUTHOR) ron.waksman@medstar.net
Source: Cardiovascular Revascularization Medicine. Dec2021, Vol. 33, p55-61. 7p.
Database: Academic Search Ultimate
Description
ISSN:15538389
DOI:10.1016/j.carrev.2021.06.016